Mounjaro®
Starting from £179.99/mo
Start journey Learn moreEach Mounjaro pen is a pre-filled, once-weekly subcutaneous injection containing tirzepatide — a dual GIP and GLP-1 receptor agonist licensed in the UK for weight management and type 2 diabetes. One pen delivers four weekly doses, and treatment always starts at 2.5mg before a prescriber titrates upward. As a prescription-only medicine, Mounjaro pens are only legally available following a clinical assessment. The NHS tirzepatide patient information page covers the basics clearly; the sections below go deeper on what the pen itself is, how to use it correctly, and what to do with it once it's empty.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The evidence base for tirzepatide is grounded in the SURMOUNT programme, and NICE's appraisal of tirzepatide (TA1026) assessed that evidence before recommending it for NHS use in eligible adults. SURMOUNT-1, which randomised 2,539 adults, found that participants at the 15mg dose achieved an average body-weight reduction of around 20–21% over 72 weeks. Those figures were generated by people using the KwikPen weekly, consistently and correctly, which is worth stating plainly, because the pen's design is part of why adherence in the trial held up as well as it did.
The pen is pre-filled and pre-set to the prescribed dose; there is no dial to turn, no cartridge to load. You attach a needle, select an injection site, press the button and the mechanism delivers the dose. That simplicity matters clinically: fewer steps means fewer opportunities for error. Still, correct technique (right site, right angle, rotating where you inject) does make a difference to both comfort and absorption.
A common belief is that the pen has to be used from the fridge immediately, straight from cold storage. In fact there is a limited window during which it may be held at room temperature, which is why the Patient Information Leaflet is the right place to check that detail rather than any general article. The leaflet is specific to your pen's batch and strength; a blog post isn't.
The three licensed injection sites for Mounjaro are the abdomen (avoiding a two-inch radius around the navel), the front or outer thigh, and the upper arm. Rotating between these sites (and rotating within each site) reduces the risk of local reactions and lipohypertrophy, a build-up of fatty tissue that can blunt absorption over time.
The pen itself does not come with a needle attached. You'll need to fit a compatible needle before each injection. Compatible needles for Mounjaro pens are stocked separately; a fresh needle should be used for every injection and removed immediately afterwards before capping the pen. Reusing needles blunts the tip and increases the risk of infection and injection-site pain, something our prescribers flag regularly because it seems like a small saving that isn't.
Before injecting, clean the chosen site with an alcohol swab and let the skin dry fully. Insert at a 90-degree angle (or 45 degrees if you have very little subcutaneous fat at the site), press the injection button firmly, and hold for a count of ten to ensure the full dose is delivered. You'll hear a click when the mechanism fires; keep the pen pressed against the skin until the ten seconds are up.
For a detailed walk-through of the injection process step by step, the Mounjaro injection guide covers technique in full.
An empty KwikPen is a clinical sharp. UK law and NHS guidance are clear: it cannot go into household recycling or a standard bin. Used pens and detached needles belong in an approved sharps container, which most councils collect free of charge via a sharps collection scheme, contact your local authority or ask your GP surgery for details.
A 1-litre sharps container is the right size for most people on a single monthly pen; it seals securely and meets the required standard for collection. Once a container is three-quarters full, seal it and arrange collection, don't overfill it.
If you are moving to a different strength or your prescription changes, return any unused sealed pens to a pharmacy for safe disposal rather than storing them indefinitely. Pens are matched to your prescribed dose; using a different strength without clinical authorisation is not appropriate. Questions about switching or pausing treatment belong with your prescriber, not the pen's label.
If you're weighing up the cost of ongoing treatment, a factual overview of how Mounjaro is priced across UK providers may help you understand what different services include.
Mounjaro pens in the UK come only through a valid prescription issued following a clinical assessment. That assessment considers your BMI, any weight-related health conditions, current medicines and medical history. No legitimate service skips that step.
The Mounjaro injection pens page covers the different pen formats available by dose. If you're approaching the end of your current supply, the guidance on starting a new Mounjaro pen is worth reading before your next dose is due. And if you've seen references to packs supplying two or three pens at once, those are covered in the two-pen supply and three-pen supply pages respectively.
At nume, every prescription is reviewed by a GPhC-registered Independent Prescriber before any treatment is dispatched. If you'd like to find out whether tirzepatide is clinically suitable for you, check your eligibility with a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.